Healthcare & Medical

8th Commercializing Industrial Biotechnology

he Commercializing Industrial Biotechnology (CIB) conference spotlights best practices, lessons learned, and technology innovations for accelerating commercial production of bio-based products and building the circular bioeconomy. This is the premier conference focused on scale-up and commercialization of new products in the synthetic biology, fermentation,…

Visit the official site

1Voices

2Underwriters

0Exhibitors

0On the bill · sessions

3Companies · in total

§I

The Voices

Programmed at 8th, in alphabetical order.

Jim Stutelberg

Chief Executive Officer · Primient

§II

Underwritten By

The houses behind the program. Tiers as disclosed.

AIChE Journal

Biotechnology Progress

Intermission

Part the Second · For the Buyer

An audience of 3 companies, parsed from the program.

“Three companies in attendance.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House

0All threespeak · spons · exh

2Sponsoringsponsor only

0Exhibitingexhibitor only

1Speakingspeaker only

№ 02Fig. 02 — The Voices, by Seniority

100% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

C-suite1100%

Of 1 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room

№ 04Fig. 04 — By Tier

unspecified2

100% of 2